Antenatal corticosteroids study (ANCS)
17 January 2017
| Position paper
Overview
A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent preterm birth in health facilities in low-resource settings to improve newborn outcomes - ANCS. Maternal and newborn health. Countries: Bangladesh, India, Kenya, Nigeria and Pakistan
WHO Team
Maternal, Newborn, Child & Adolescent Health & Ageing (MCA),
Newborn Health (NBH)
Editors
WHO
Number of pages
2